ArticleJournal of cancer research and clinical oncology2019

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.

Aristomenis Anestis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.